iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease ; day:5 ; month:6 ; year:2024 ; pages:1-9
Molecular psychiatry ; (5.6.2024), 1-9
- Urheber
-
Zivko, Cristina
Sagar, Ram
Xydia, Ariadni
Lopez-Montes, Alejandro
Mintzer, Jacobo
Rosenberg, Paul B.
Shade, David M.
Porsteinsson, Anton P.
Lyketsos, Constantine G.
Mahairaki, Vasiliki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-024-02629-y
- URN
-
urn:nbn:de:101:1-2408131154393.087779009573
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zivko, Cristina
- Sagar, Ram
- Xydia, Ariadni
- Lopez-Montes, Alejandro
- Mintzer, Jacobo
- Rosenberg, Paul B.
- Shade, David M.
- Porsteinsson, Anton P.
- Lyketsos, Constantine G.
- Mahairaki, Vasiliki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Causal influences of neuropsychiatric disorders on Alzheimer’s disease
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
Analysis of Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease Using Quantitative EEG and sLORETA
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Causal influences of neuropsychiatric disorders on Alzheimer’s disease
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
Analysis of Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease Using Quantitative EEG and sLORETA
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Causal influences of neuropsychiatric disorders on Alzheimer’s disease
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids